Toray Industries, Inc.

Nobutaka Ida

Hajimu Kurumatani

Masahiko Takenaka

Yoshihisa Yamane

Nobuo Ida

Masanobu Naruto

Katsuaki Kojima

Reiji Kasukawa

Masayuki Miyata

Yu-ichiro Sato

A method of ameliorating symptoms of uremia includes administering a therapeutic agent including beraprost or each isomer constituting beraprost, or a salt thereof as an effective ingredient to an animal belonging to the Family Canidae, wherein an effective dosage is a dosage that does not significantly lower blood pressure.

Method of ameliorating uremia

A therapeutic agent and a treatment method for uremia of human and animals, which therapeutic agent can be easily taken, has lower side effects, and which is not expensive in view of medical economics, are disclosed. The therapeutic agent for uremia in patients suffering from chronic renal failure comprises as an effective ingredient a prostaglandin Iderivative having a specific structure, such as beraprost sodium. The therapeutic agent for uremia ameliorates the uremia concurred in patients with chronic renal failure without accompanying side effects, and restoration of decreased appetite, improvements in activities, increase in body weight and the like are achieved. The therapeutic effect of uremia is clear alleviation or disappearance of symptoms of uremia grasped as clinical symptoms, observed in the state of renal failure, especially even in spite of the state wherein the decrease in renal function is progressed.

Therapeutic agent and treatment method for ameliorating uremia

Drug for prevention and therapy of diseases caused by fibrinoid

Growing community of inventors

Kamakura, Japan

Nobutaka Ida